Retatrutide is an investigational peptide compound that acts as a triple agonist, targeting three hormone receptors simultaneously: glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon receptors
Potent antinociceptive effect of centrally administered delta-sleep-inducing peptide (DSIP)
The recommended dietary allowance (RDA) for B12 in adults is 2.4mcg, rising to 2.6mcg for pregnant women and 2.8mcg for breastfeeding women
If you see persistent pain, redness, or itching at the site of the injection, mild diarrhea, swelling sensation in your body, or temporary itching in your skin, contact your doctor immediately
References: Minich DM, Brown BI